Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate.

Vidal-Calvo EE, Martin-Salazar A, Choudhary S, Dagil R, Raghavan SSR, Duvnjak L, Nordmaj MA, Clausen TM, Skafte A, Oberkofler J, Wang K, Agerbæk MØ, Løppke C, Jørgensen AM, Ropac D, Mujollari J, Willis S, Garcias López A, Miller RL, Karlsson RTG, Goerdeler F, Chen YH, Colaço AR, Wang Y, Lavstsen T, Martowicz A, Nelepcu I, Marzban M, Oo HZ, Ørum-Madsen MS, Wang Y, Nielsen MA, Clausen H, Wierer M, Wolf D, Gögenur I, Theander TG, Al-Nakouzi N, Gustavsson T, Daugaard M, Salanti A.

Open source

DOI: 10.1038/s41467-024-51781-0
Published: 2024-08-30
Container: Nat Commun
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-024-51781-0,
  title = {Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate.},
  author = {Vidal-Calvo EE and  Martin-Salazar A and  Choudhary S and  Dagil R and  Raghavan SSR and  Duvnjak L and  Nordmaj MA and  Clausen TM and  Skafte A and  Oberkofler J and  Wang K and  Agerbæk MØ and  Løppke C and  Jørgensen AM and  Ropac D and  Mujollari J and  Willis S and  Garcias López A and  Miller RL and  Karlsson RTG and  Goerdeler F and  Chen YH and  Colaço AR and  Wang Y and  Lavstsen T and  Martowicz A and  Nelepcu I and  Marzban M and  Oo HZ and  Ørum-Madsen MS and  Wang Y and  Nielsen MA and  Clausen H and  Wierer M and  Wolf D and  Gögenur I and  Theander TG and  Al-Nakouzi N and  Gustavsson T and  Daugaard M and  Salanti A.},
  year = {2024},
  journal = {Nat Commun},
  doi = {10.1038/s41467-024-51781-0},
  url = {https://doi.org/10.1038/s41467-024-51781-0}
}

RIS

TY  - JOUR
TI  - Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate.
AU  - Vidal-Calvo EE
AU  -  Martin-Salazar A
AU  -  Choudhary S
AU  -  Dagil R
AU  -  Raghavan SSR
AU  -  Duvnjak L
AU  -  Nordmaj MA
AU  -  Clausen TM
AU  -  Skafte A
AU  -  Oberkofler J
AU  -  Wang K
AU  -  Agerbæk MØ
AU  -  Løppke C
AU  -  Jørgensen AM
AU  -  Ropac D
AU  -  Mujollari J
AU  -  Willis S
AU  -  Garcias López A
AU  -  Miller RL
AU  -  Karlsson RTG
AU  -  Goerdeler F
AU  -  Chen YH
AU  -  Colaço AR
AU  -  Wang Y
AU  -  Lavstsen T
AU  -  Martowicz A
AU  -  Nelepcu I
AU  -  Marzban M
AU  -  Oo HZ
AU  -  Ørum-Madsen MS
AU  -  Wang Y
AU  -  Nielsen MA
AU  -  Clausen H
AU  -  Wierer M
AU  -  Wolf D
AU  -  Gögenur I
AU  -  Theander TG
AU  -  Al-Nakouzi N
AU  -  Gustavsson T
AU  -  Daugaard M
AU  -  Salanti A.
PY  - 2024
JO  - Nat Commun
DO  - 10.1038/s41467-024-51781-0
UR  - https://doi.org/10.1038/s41467-024-51781-0
ER  -

APA

EE, V., A, M., S, C., R, D., SSR, R., L, D., MA, N., TM, C., A, S., J, O., K, W., MØ, A., C, L., AM, J., D, R., J, M., S, W., A, G. L., RL, M., RTG, K., F, G., YH, C., AR, C., Y, W., T, L., A, M., I, N., M, M., HZ, O., MS, Ø., Y, W., MA, N., H, C., M, W., D, W., I, G., TG, T., N, A., T, G., M, D., & A., S. (2024). Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate.. Nat Commun. https://doi.org/10.1038/s41467-024-51781-0

Source records

europe-pmc · retrieved 2026-09-25T23:57:12.794Z
doaj · retrieved 2026-09-25T23:57:12.801Z